Skip to search.
 TSX Up 0.27% TSX Ventures Up 0.18%

BioMarin Pharmaceutical Inc. (BMRN)

-NasdaqGS
120.95 Down 3.67(2.94%) Apr 1, 4:00PM EDT
|After Hours : 120.96 Up 0.01 (0.01%) Apr 1, 7:45PM EDT
Add to Portfolio
Prev Close:124.62
Open:124.61
Bid:120.01 x 300
Ask:129.00 x 300
1y Target Est:126.32
Beta:1.14
Earnings Date:Apr 29 - May 4 (Est.)
Day's Range:118.22 - 124.75
52wk Range:55.04 - 133.54
Volume:2,105,077
Avg Vol (3m):1,601,030
Market Cap:19.25B
P/E (ttm):N/A
EPS (ttm):-0.92
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
BMRNDown 2.94%19.25B
FOLDUp 1.01%1.05B
SHPGDown 2.71%45.55B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):26.41
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-15) :-2.31
Quarterly EPS Est (Mar-15) :-0.53
Mean Recommendation*:1.8
PEG Ratio (5 yr expected):-2.09

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

BioMarin Pharmaceutical Inc. develops and commercializes pharmaceuticals for serious diseases and medical conditions in the United States, Europe, Latin America, and internationally. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback